Prevalence and Associated Risk Factors for Obesity During Pregnancy Over Time
T N Stüber1, E C Künzel1, U Zollner1
1Department of Obstetrics and Gynecology, University of Würzburg, Würzburg.
Geburtshilfe Und Frauenheilkunde
|October 27, 2015
Summary
Obesity in pregnant women is rising, with most overweight or obese mothers exceeding recommended weight gain. This trend is linked to increased gestational diabetes, hypertension, and cesarean births, though fetal outcomes remain unaffected.
Area of Science:
- Obstetrics and Gynecology
- Public Health
- Maternal-Fetal Medicine
Background:
- Rising global obesity rates impact maternal morbidity.
- Young adult women are increasingly affected by weight gain.
- Understanding obesity's impact on pregnancy is crucial.
Purpose of the Study:
- Evaluate obesity prevalence in a local cohort (2006 vs. 2011).
- Identify associated maternal risk factors and pregnancy complications.
- Assess fetal outcomes in relation to maternal obesity.
Main Methods:
- Retrospective analysis of maternal and fetal records from 2006 and 2011.
- Inclusion of 2838 singleton pregnancies.
- Descriptive statistics and association analysis between obesity and complications.
Main Results:
- No significant increase in pre-pregnancy BMI or weight gain between 2006 and 2011.
- Majority of overweight (71%) and obese (60.4%) mothers exceeded recommended weight gain.
- Significant increases in gestational diabetes, gestational hypertension, and preeclampsia, associated with higher BMI; cesarean delivery also increased.
Conclusions:
- Trend towards excessive weight gain during pregnancy, particularly in obese mothers.
- Increased prevalence of gestational diabetes, hypertension, and cesarean deliveries linked to maternal obesity.
- Maternal obesity did not negatively impact fetal outcomes or prolong pregnancy.
Related Concept Videos
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:20Pathophysiology of Diabetes
4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
01:22Diabetes Mellitus: Type 2 and Gestational
5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
381
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
283
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
283
01:21Drug Dosing: Obese Patients
341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341